BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3776104)

  • 1. [Enzymologically different characteristics between influenza A and B virus neuraminidases].
    Takei N; Kiyotani K; Senoo M; Matsuo Y
    Uirusu; 1986 Jun; 36(1):119-23. PubMed ID: 3776104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiochemical properties of purified and virion neuraminidases of the influenza B viruses].
    Brydak L; Liubotseva OV; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(2):156-9. PubMed ID: 3604184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies on the sialidase of three influenza B and three influenza A virus strains.
    Cabezas JA; Milicua M; Bernal CS; Villar E; Perez N; Hannoun C
    Glycoconj J; 1989; 6(2):219-27. PubMed ID: 2535486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymological characteristics of avian influenza A virus neuraminidase.
    Kiyotani K; Takei N; Senoo M; Takao S; Otsuki K; Tsubokura M; Yoshida T
    Microbiol Immunol; 1987; 31(11):1131-5. PubMed ID: 2451112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of substrate specificities of sialidase activity between purified enzymes from influenza virus A (H1N1 and H3N2 subtypes) and B strains and their original viruses.
    Nagai T; Suzuki Y; Yamada H
    Biol Pharm Bull; 1995 Sep; 18(9):1251-4. PubMed ID: 8845816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains.
    Kati WM; Saldivar AS; Mohamadi F; Sham HL; Laver WG; Kohlbrenner WE
    Biochem Biophys Res Commun; 1998 Mar; 244(2):408-13. PubMed ID: 9514938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZstatFlu-II test: a chemiluminescent neuraminidase assay for influenza viral diagnostics.
    Achyuthan KE; Pence LM; Appleman JR; Shimasaki CD
    Luminescence; 2003; 18(3):131-9. PubMed ID: 12701088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymological heterogeneity of influenza B virus neuraminidase demonstrated by the fluorometric assay method.
    Kiyotani K; Takei N; Matsuo Y
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):273-85. PubMed ID: 2867656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sialidase activity as a therapeutic approach.
    Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
    Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
    Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of bromoindolyl 4,7-di-O-methyl-Neu5Ac: specificity toward influenza A and B viruses.
    Liav A; Hansjergen JA; Achyuthan KE; Shimasaki CD
    Carbohydr Res; 1999 Apr; 317(1-4):198-203. PubMed ID: 10466215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
    Deshairs C; Kessler N; Aymard M; Quash GA
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus.
    Hart GJ; Bethell RC
    Biochem Mol Biol Int; 1995 Jul; 36(4):695-703. PubMed ID: 8528132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza type B neuraminidase can replace the function of type A neuraminidase.
    Ghate AA; Air GM
    Virology; 1999 Nov; 264(2):265-77. PubMed ID: 10562491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus neuraminidase activates latent transforming growth factor beta.
    Schultz-Cherry S; Hinshaw VS
    J Virol; 1996 Dec; 70(12):8624-9. PubMed ID: 8970987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of low pH values on the infectivity and neuraminidase activity of human and animal strains of influenza virus type A].
    Glathe H; Strittmatter HU; Kunze M; Sinnecker H
    Acta Biol Med Ger; 1982; 41(11):1075-8. PubMed ID: 7170871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The rapid detection kit based on neuraminidase activity of influenza virus].
    Shimizu H
    Nihon Rinsho; 2000 Nov; 58(11):2234-7. PubMed ID: 11225310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
    Rakers C; Schwerdtfeger SM; Mortier J; Duwe S; Wolff T; Wolber G; Melzig MF
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4312-7. PubMed ID: 25096296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete metal ion requirement of influenza virus N1 neuraminidases. Brief report.
    Carroll SM; Paulson JC
    Arch Virol; 1982; 71(3):273-7. PubMed ID: 6808973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of influenza viral neuraminidase (NA) revealed by large-scale sequence analysis.
    Xu J; Lu G
    Influenza Other Respir Viruses; 2011 May; 5(Suppl 1):405-8. PubMed ID: 21761592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.